272 related articles for article (PubMed ID: 35397551)
1. Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.
Dubé K; Kanazawa J; Patel H; Louella M; Sylla L; Sheehy J; Dee L; Taylor J; Adair J; Anthony-Gonda K; Dropulić B; Sauceda JA; Peluso MJ; Deeks SG; Simoni J
BMC Med Ethics; 2022 Apr; 23(1):39. PubMed ID: 35397551
[TBL] [Abstract][Full Text] [Related]
2. Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States.
Dubé K; Kanazawa J; Dee L; Taylor J; Sauceda JA; Gianella S; Smith D; Deeks SG; Peluso MJ
AIDS Res Ther; 2021 Oct; 18(1):75. PubMed ID: 34663375
[TBL] [Abstract][Full Text] [Related]
3. Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.
Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings SA; Hendrickx S; Little S; Brown B; Smith D; Dubé K
BMC Med Ethics; 2022 Jan; 23(1):2. PubMed ID: 35012544
[TBL] [Abstract][Full Text] [Related]
4. Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.
Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings S; Hendrickx S; Little S; Brown B; Smith D; Dubé K
PLoS One; 2021; 16(7):e0254148. PubMed ID: 34270612
[TBL] [Abstract][Full Text] [Related]
5. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
[TBL] [Abstract][Full Text] [Related]
6. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
[No Abstract] [Full Text] [Related]
7. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry.
Dubé K; Dee L; Evans D; Sylla L; Taylor J; Brown B; Miller V; Corneli A; Skinner A; Greene SB; Tucker JD; Rennie S
J Empir Res Hum Res Ethics; 2018 Feb; 13(1):3-17. PubMed ID: 28984168
[TBL] [Abstract][Full Text] [Related]
9. The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa.
Moodley K; Staunton C; Rossouw T; de Roubaix M; Duby Z; Skinner D
BMC Med Ethics; 2019 Jan; 20(1):9. PubMed ID: 30678664
[TBL] [Abstract][Full Text] [Related]
10. Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.
Dubé K; Barr E; Philbin M; Perez-Brumer A; Minalga B; Peterson B; Averitt D; Picou B; Martel K; Chung C; Mejía M; Cameron M; Graham G; Dee L; Dixon Diallo D; Gordon E; Korolkova A; Dyer T; Auerbach JD; Scully E; Dong KL; Gianella S
HIV Res Clin Pract; 2023 Aug; 24(1):2246717. PubMed ID: 37608645
[TBL] [Abstract][Full Text] [Related]
11. Ethical considerations for HIV cure-related research at the end of life.
Dubé K; Gianella S; Concha-Garcia S; Little SJ; Kaytes A; Taylor J; Mathur K; Javadi S; Nathan A; Patel H; Luter S; Philpott-Jones S; Brown B; Smith D
BMC Med Ethics; 2018 Oct; 19(1):83. PubMed ID: 30342507
[TBL] [Abstract][Full Text] [Related]
12. Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa.
Moodley K; Rossouw T; Staunton C; Colvin CJ
BMC Med Ethics; 2016 Apr; 17(1):26. PubMed ID: 27137204
[TBL] [Abstract][Full Text] [Related]
13. Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.
Allman D; Ditmore MH; Kaplan K
PLoS One; 2014; 9(6):e100058. PubMed ID: 24949864
[TBL] [Abstract][Full Text] [Related]
14. Ethics of HIV cure research: an unfinished agenda.
Dubé K; Kanazawa J; Taylor J; Dee L; Jones N; Roebuck C; Sylla L; Louella M; Kosmyna J; Kelly D; Clanton O; Palm D; Campbell DM; Onaiwu MG; Patel H; Ndukwe S; Henley L; Johnson MO; Saberi P; Brown B; Sauceda JA; Sugarman J
BMC Med Ethics; 2021 Jun; 22(1):83. PubMed ID: 34193141
[TBL] [Abstract][Full Text] [Related]
15. Practical and Ethical Concerns in Implementing Enhanced Surveillance Methods to Improve Continuity of HIV Care: Qualitative Expert Stakeholder Study.
Buchbinder M; Blue C; Rennie S; Juengst E; Brinkley-Rubinstein L; Rosen DL
JMIR Public Health Surveill; 2020 Sep; 6(3):e19891. PubMed ID: 32886069
[TBL] [Abstract][Full Text] [Related]
16. Ethical considerations for involving adolescents in biomedical HIV prevention research.
Nakalega R; Akello C; Gati B; Nakabiito C; Nolan M; Kamira B; Etima J; Nakyanzi T; Kemigisha D; Nanziri SC; Nanyonga S; Nambusi MJ; Mulumba E; Biira F; Nabunya HK; Akasiima SA; Nansimbe J; Maena J; Babirye JA; Ngure K; Mujugira A
BMC Med Ethics; 2021 Sep; 22(1):127. PubMed ID: 34556099
[TBL] [Abstract][Full Text] [Related]
17. Physicians' and Machine Learning Researchers' Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study.
Kim JP; Ryan K; Kasun M; Hogg J; Dunn LB; Roberts LW
JMIR AI; 2023 Oct; 2():e47449. PubMed ID: 38875536
[TBL] [Abstract][Full Text] [Related]
18. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
[TBL] [Abstract][Full Text] [Related]
19. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
[TBL] [Abstract][Full Text] [Related]
20. "I would really want to know that they had my back": Transgender women's perceptions of HIV cure-related research in the United States.
Poteat T; Aqil A; Corbett D; Evans D; Dubé K
PLoS One; 2020; 15(12):e0244490. PubMed ID: 33382760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
